I-SENS, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
May 13, 2024 at 01:23 am
Share
i-SENS, Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was KRW 413.85 million compared to KRW 218.65 million a year ago. Net loss was KRW 261.44 million compared to net income of KRW 4,214.1 million a year ago.
Basic loss per share from continuing operations was KRW 10 compared to basic earnings per share from continuing operations of KRW 153 a year ago. Diluted loss per share from continuing operations was KRW 9. Basic loss per share was KRW 10 compared to basic earnings per share of KRW 153 a year ago. Diluted loss per share was KRW 9.
i-SENS, Inc. is a Korea-based company mainly engaged in the manufacture and sale of biosensors. The Companyâs products consist of blood glucose monitoring systems, including blood glucose monitors, blood glucose meters, glucose monitors, blood glucose meter kits and blood sugar meters under the brand names of CareSens, MedTrust, BGStar, Barozen and others; electrolyte analyzers and cartridges; immunosensors, as well as other related accessories, such as connectors, lancets, blood glucose data management software and lancing devices, among others. The Company distributes its products within domestic market and to overseas markets including Japan, Europe, the United States and others.